Vizirgianakis Stavros G.
- SEC CIK
- 0001559834
No open-market purchases or sales filed in the past year.
Current role at each company
- XTNT Xtant Medical Holdings, Inc.Directoras of Aug 18, 2026
- APYX Apyx Medical CorpDirectoras of Jun 15, 2026
- BVS Bioventus Inc.Directoras of Jun 22, 2022
- MSON Misonix IncPresident and CEOas of Dec 8, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vizirgianakis Stavros G. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XTNT Xtant Medical Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 11, 2022 (view filing)4:48 PM ET | Oct 7 | 4 days | Vizirgianakis Stavros G.Director | PPurchaseCommon Stock, $0.000001 par value | +2.26M | $0.48 | +$1.09M | +63.2%5.85M after | |
| Oct 11, 2022 (view filing)4:48 PM ET | Oct 7 | 4 days | Vizirgianakis Stavros G.Director | PPurchase | +566.2K | $0.00 | $0 | –566.2K after | Derivative |